BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11685114)

  • 1. Alterations in transcription factor binding at the IL-2 promoter region in anergized human CD4+ T lymphocytes.
    Heisel O; Keown P
    Transplantation; 2001 Oct; 72(8):1416-22. PubMed ID: 11685114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells.
    Mondino A; Whaley CD; DeSilva DR; Li W; Jenkins MK; Mueller DL
    J Immunol; 1996 Sep; 157(5):2048-57. PubMed ID: 8757326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors.
    Sundstedt A; Sigvardsson M; Leanderson T; Hedlund G; Kalland T; Dohlsten M
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):979-84. PubMed ID: 8577772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo anergized CD4+ T cells have defective expression and function of the activating protein-1 transcription factor.
    Sundstedt A; Dohlsten M
    J Immunol; 1998 Dec; 161(11):5930-6. PubMed ID: 9834073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL; Iacobelli M
    J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced transcription factor binding at the IL-2 promoter region in anergized human CD4+ T lymphocytes.
    Heisel O; Keown P
    Transplant Proc; 1999; 31(1-2):780. PubMed ID: 10083331
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.
    Leu JI; Crissey MA; Leu JP; Ciliberto G; Taub R
    Mol Cell Biol; 2001 Jan; 21(2):414-24. PubMed ID: 11134330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy.
    Powell JD; Lerner CG; Ewoldt GR; Schwartz RH
    J Immunol; 1999 Dec; 163(12):6631-9. PubMed ID: 10586058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.
    Gringhuis SI; de Leij LF; Verschuren EW; Borger P; Vellenga E
    Blood; 1997 Oct; 90(7):2690-700. PubMed ID: 9326236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential induction of the NF-AT complex during restimulation and the induction of T-cell anergy.
    Wotton D; Higgins JA; O'Hehir RE; Lamb JR; Lake RA
    Hum Immunol; 1995 Feb; 42(2):95-102. PubMed ID: 7744623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription.
    Zhang J; Salojin KV; Delovitch TL
    Int Immunol; 2001 Mar; 13(3):377-84. PubMed ID: 11222507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.
    Grundström S; Dohlsten M; Sundstedt A
    J Immunol; 2000 Feb; 164(3):1175-84. PubMed ID: 10640728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells.
    Harris JE; Bishop KD; Phillips NE; Mordes JP; Greiner DL; Rossini AA; Czech MP
    J Immunol; 2004 Dec; 173(12):7331-8. PubMed ID: 15585857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity.
    Jabado N; Le Deist F; Fisher A; Hivroz C
    Eur J Immunol; 1994 Nov; 24(11):2646-52. PubMed ID: 7957556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two pathways can activate the interleukin-5 gene and induce binding to the conserved lymphokine element 0.
    Karlen S; D'Ercole M; Sanderson CJ
    Blood; 1996 Jul; 88(1):211-21. PubMed ID: 8704176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increase in the induction of IL-2 expression with caloric restriction is correlated to changes in the transcription factor NFAT.
    Pahlavani MA; Harris MD; Richardson A
    Cell Immunol; 1997 Aug; 180(1):10-9. PubMed ID: 9316634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
    González E; Punzón C; González M; Fresno M
    J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter.
    Botelho FM; Edwards DR; Richards CD
    J Biol Chem; 1998 Feb; 273(9):5211-8. PubMed ID: 9478976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
    Jenkins F; Cockerill PN; Bohmann D; Shannon MF
    J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in the expression of IL-2 after trauma and changes in the nuclear transcription factors NFAT and AP-1.
    Luo Y; Liang H; Hu C; Xu X; Wang Z
    Chin Med J (Engl); 2002 Sep; 115(9):1348-51. PubMed ID: 12411110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.